Verastem Inc (VSTM)
$1.33
0.03 (2.31%)
VSTM Stock Quote Delayed 15 Minutes
Previous Close
$1.33
Market Cap
88.11M
PE Ratio
-0.73
EPS
-1.82
Volume (Avg. Vol.)
525,700
Day's Range
1.28 - 1.33
52-Week Range
1.16 - 9.32
Dividend & Yield
N/A (N/A)
VSTM Stock Predictions, Articles, and Verastem Inc News
3 Stocks to Watch on Friday: DDR Corp (DDR), Hess Corp. (HES) and Verastem Inc (VSTM)
DDR (DDR) to spin off 50 properties, Hess (HES) to dethrone John Hess as CEO and Verastem (VSTM) announces $25 million common share offering.
24 Biotechnology Stocks to Sell Now
This week, the ratings of 24 Biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
32 Biotechnology Stocks to Sell Now
This week, the overall grades of 32 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
11 Biotechnology Stocks to Sell Now
This week, the overall grades of 11 biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
9 Biotechnology Stocks to Sell Now
The ratings of nine biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
9 Biotechnology Stocks to Sell Now
The ratings of nine biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
8 Biotechnology Stocks to Sell Now
This week, the overall grades of eight biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
9 Biotechnology Stocks to Sell Now
The overall ratings of nine biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
10 Biotechnology Stocks to Sell Now
This week, the ratings of 10 biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
10 Biotechnology Stocks to Sell Now
The overall ratings of 10 biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
9 Biotechnology Stocks to Sell Now
The ratings of nine biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
9 Biotechnology Stocks to Sell Now
For the current week, the overall ratings of nine biotechnology stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
10 Biotechnology Stocks to Sell Now
For the current week, the overall ratings of 10 biotechnology stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
10 Biotechnology Stocks to Sell Now
This week, the overall grades of 10 biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
10 Biotechnology Stocks to Sell Now
The ratings of 10 biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
11 Biotechnology Stocks to Sell Now
This week, the ratings of 11 biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
13 Biotechnology Stocks to Sell Now
This week, the ratings of 13 biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Navellier Ratings
Powered by Portfolio GraderTotal Grade
F
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!
